Public Reporting | USMM LLC ACO

Name and Location
USMM Accountable Care Partners, LLC
Previous Names: N/A
500 Kirts Blvd.
Troy, MI 48084

Primary Contact
Joan Valentine
Email: jvalentine@usmmllc.com
Phone: 248-434-6222

ACP Participants

ACO Participants	ACO Participant in Joint Venture (Enter Y or N)
VPA of Texas, PLLC	N
RMED, LLC	N
VPA, PC	N

ACO Governing Body

Member First Name	Member Last Name	Member Title/Position	Member's Voting Power	Membership Type	ACO Participant Legal Business Name and D/B/A, if applicable
Matt	Chance	Manager	10	ACO Participant Representative	RMed, LLC
Joan	Valentine	Manager	10	Other	N/A
Basil	Younis	Manager	10	ACO Participant Representative	VPA of Texas, PLLC
Zack	Mulligan	Manager	10	ACO Participant Representative	RMed, LLC
Stefanie	Cain	Manager	10	ACO Participant Representative	VPA, P.C.
Annemarie	Daily	CMO/Manager	10	ACO Participant Representative	VPA, P.C.
Margaret	Wadas-Enright	Manager	10	ACO Participant Representative	VPA of Texas, PLLC
Bhavesh	Patel	Manager	10	ACO Participant Representative	RMed, LLC
Lynn	Beatty Athens	Manager	10	ACO Participant Representative	VPA, P.C.
Ann	Pappas	Manager	10	Medicare beneficiary representative	N/A

ACO Clinical and Administrative Leadership

Key ACO Clinical and Administrative Leadership

Chairperson: Matt Chance
Vice-Chairperson: Joan Valentine
Treasurer: Zack Mulligan
Secretary: Stephanie Olsen
Medical Director: Annemarie Daly
Chief Compliance Officer: Chichi Onoriobe

Associated Committees and Committee Leaderships

Care Management - Care Management Eric McKeon, VP - Clinical Programs and Pharmacy
Quality Management & Peer Review - Joan Valentine, Exec. V.P., VPA
Finance - Care Management Eric McKeon, VP - Clinical Programs and Pharmacy
Compliance - Chichi Onoriobe, Director Quality Operations

Types of ACO Participants, or Combinations of Participants, That Formed the ACO

Networks of individual practices of ACO professionals

• Third Agreement Period
o Performance Year 2021, $25,813,466.19
o Performance Year 2020, $19,404,826.74
o Performance Year 2019-A, $0
• Second Agreement Period
o Performance Year 2019, $0
• First Agreement Period
o Performance Year 2018, $12,620,610
o Performance Year 2017, $20,750,377
o Performance Year 2016, $21,195,787
o Performance Year 2015, $7,393,855

Shared Savings Distribution

Third Agreement Period
- Performance Year 2021
  - Proportion invested in infrastructure: 10%
  - Proportion invested in redesigned care processes/resources: 15%
  - Proportion of distribution to ACO participants: 75%
  - Third Agreement Period
  - Performance Year 2020
    - Proportion invested in infrastructure: 20%
    - Proportion invested in redesigned care processes/resources: 59%
    - Proportion of distribution to ACO participants: 21%
    - Third Agreement Period
  - Performance Year 2019-A
    - Proportion invested in infrastructure: 0%
    - Proportion invested in redesigned care processes/resources: 0%
    - Proportion of distribution to ACO participants: 0%
- Second Agreement Period
  - Performance Year 2019
    - Proportion invested in infasinfrastructure: 0%
    - Proportion invested in redesigned care processes/resources: 0%
    - Proportion of distribution to ACO participants: 0%
- First Agreement Period
  - Performance Year 2018
    - Proportion invested in infrastructure: 31%
    - Proportion invested in redesigned care processes/resources: 37%
    - Proportion of distribution to ACO participants: 32%
  - Performance Year 2017
    - Proportion invested in infrastructure: 14%
    - Proportion invested in redesigned care processes/resources: 67%
    - Proportion of distribution to ACO participants: 19%
  - Performance Year 2016
    - Proportion invested in infrastructure: 13%
    - Proportion invested in redesigned care processes/resources: 68%
    - Proportion of distribution to ACO participants: 19%
  - Performance Year 2015
    - Proportion invested in infrastructure: 60%
    - Proportion invested in redesigned care processes/resources: 15%
    - Proportion of distribution to ACO participants: 25%

Quality Performance Results

2021 Quality Performance Results:

Quality performance results are based on MIPS CQMs

ACO Quality Measure Number	Measure Name	Rate	ACO Mean
001	Diabetes: Hemoglobin A1c (HbA1c) Poor	27.36	40.68
134	Preventative Care and Screening: Screening for Depression and Follow-up	86.48	51.53
236	Controlling High Blood Pressure	79.19	69.61
321	CAHPS for MIPS3	N/A	N/A
479	Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for	0.1685	0.1685
MCC1	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions	39.41	33.99
CAHPS-1	Getting Timely Care, Appointments, and	79.06	84.67
CAHPS-2	How Well Providers Communicate	92.24	93.56
CAHPS-3	Patient’s Rating of Provider	90.47	92.19
CAHPS-4	Access to Specialists	71.76	78.80
CAHPS-5	Health Promotion and Education	60.74	61.61
CAHPS-6	Shared Decision Making	54.38	60.89
CAHPS-7	Health Status and Functional Status	51.76	71.78
CAHPS-8	Care Coordination	79.67	85.66
CAHPS-9	Courteous and Helpful Office Staff	87.44	91.88
CAHPS-11	Stewardship of Patient Resources	29.25	24.71

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

Skilled Nursing Facility (SNF) 3-day Rule Waiver:
- Yes, our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR 425.612.
Waiver for Payment for Telehealth Services:
- Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR 425.612(f) and 42 CFR 425.613.

Fraud and Abuse Waivers

ACO Pre-Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Pre-Participation Waiver, including any material amendment or modification to a disclosed arrangement.

Not Applicable

ACO Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

MSSP Participation Waiver